$79.970
+0.040 (+0.05%)收盤時
- High
- 79.990
- Open
- 79.970
- VWAP
- 79.97
- Vol
- 2.36M
- Mkt Cap
- 2.73B
- Low
- 79.960
- Amount
- 188.66M
- EV/EBITDA, TTM
- 243.88
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.
估值指標
事件時間軸
資訊
7.002-25GlobenewswireInari Medical, Figs Inc, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
8.502-14NASDAQ.COMKadant To Replace Inari Medical In S&P SmallCap 600
7.002-05GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, TGI, AVAV, NARI on Behalf of Shareholders
7.002-05GlobenewswireKuehn Law Encourages FNA, TGI, AVAV, and NARI Investors to Contact Law Firm
7.002-03PRnewswireSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates NARI, FNA, AZPN, TURN on Behalf of Shareholders
NARI FAQ — answered by Alphio AI
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。